Gritstone Bio Inc (GRTS)
0.7826
+0.04
(+4.82%)
USD |
NASDAQ |
May 17, 16:00
0.7826
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Shareholders Equity (Quarterly): 13.96M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 13.96M |
December 31, 2023 | 51.85M |
September 30, 2023 | 73.98M |
June 30, 2023 | 109.57M |
March 31, 2023 | 140.88M |
December 31, 2022 | 170.78M |
September 30, 2022 | 136.85M |
June 30, 2022 | 163.38M |
March 31, 2022 | 189.19M |
December 31, 2021 | 216.09M |
September 30, 2021 | 207.96M |
June 30, 2021 | 178.82M |
March 31, 2021 | 199.35M |
Date | Value |
---|---|
December 31, 2020 | 166.74M |
September 30, 2020 | 71.98M |
June 30, 2020 | 96.23M |
March 31, 2020 | 115.39M |
December 31, 2019 | 134.34M |
September 30, 2019 | 156.40M |
June 30, 2019 | 182.38M |
March 31, 2019 | 132.22M |
December 31, 2018 | 149.12M |
September 30, 2018 | 72.69M |
June 30, 2018 | 78.67M |
December 31, 2017 | 97.28M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
13.96M
Minimum
Mar 2024
216.09M
Maximum
Dec 2021
138.81M
Average
148.64M
Median
Shareholders Equity (Quarterly) Benchmarks
Precision BioSciences Inc | 37.21M |
Humacyte Inc | 26.15M |
Verastem Inc | 46.22M |
BioVie Inc | 7.491M |
Adial Pharmaceuticals Inc | 4.084M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 137.21M |
Total Liabilities (Quarterly) | 123.25M |
Debt to Equity Ratio | 2.888 |
Current Ratio | 2.004 |
Net Debt Paydown Yield | -1.66% |